<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01247740</url>
  </required_header>
  <id_info>
    <org_study_id>HC-G-H-0805</org_study_id>
    <nct_id>NCT01247740</nct_id>
  </id_info>
  <brief_title>Comparison of Three-chamber-bag Versus Compounded Bag</brief_title>
  <official_title>A Prospective, Controlled, Randomized, Blinded, Parallel Group Multicentre Study on the Safety and Efficacy of a Convenience Three-chamber Bag for Parenteral Nutrition in Post-operative Patients After Abdominal Surgery Versus a Compounded Monobag</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>B. Braun Melsungen AG</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>B. Braun Melsungen AG</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study is to investigate the efficacy and safety of a convenient
      3-chamber-bag containing aminoacids, glucose and lipid emulsion (LCT/MCT 20%) compared to a
      conventionally compounded monobag for parenteral nutrition.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>October 2010</start_date>
  <completion_date type="Actual">October 2011</completion_date>
  <primary_completion_date type="Actual">October 2011</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Course of prealbumin (from day 1 to day 7)</measure>
    <time_frame>7 days</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>clinical outcome parameters, haematology, liver function, blood biochemistry and electrolytes, coagulation function</measure>
    <time_frame>7 days</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">240</enrollment>
  <condition>Parenteral Nutrition for Patients With Proven Insufficient Enteral Resorption</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>three chamber bag for parenteral nutrition containing lipids, glucose, amino acids and electrolytes</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>compounded monobag including lipids, glucose, amino acids and electrolytes</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>NuTRIflex Lipid peri</intervention_name>
    <description>parenteral nutrition</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>compounded monobag</intervention_name>
    <description>parenteral nutrition</description>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion: •Patients considered for elective open abdominal surgery

          -  Male and female patients ≥18 and &lt;85 years of age

          -  Indication for total parenteral nutrition therapy: for 6 consecutive days

          -  NRS ≥3

          -  Ability and willingness to give voluntary consent to participate in the study,
             following a full explanation of the nature and purpose of the study, by signing the
             informed consent form approved by the Institutional Review Board (IRB) prior to all
             evaluations, and to comply with the requirements of the study

        Exclusion: Major criteria:

          -  Body weight &lt; 50 kg or &gt; 70 kg

          -  Laparoscopic surgery

          -  Seriously ill patients in need of high energy nutrition support (i. e. &gt; 2100
             Kcal/day)

          -  Hepatic surgery

          -  Surgery with estimated blood loss &gt;1000ml

          -  Participation in a clinical study with an investigational drug or an investigational
             medical device within one month prior to the start of study

          -  Receiving regular parenteral nutrition within 7 days before the onset of study

          -  General contraindications for parenteral nutrition (acidosis of various geneses,
             untreated disorders of electrolyte and fluid balance, hyperhydration, acute pulmonary
             edema, inadequate cellular oxygen supply)

          -  General contraindications for infusion therapy such as acute pulmonary oedema,
             hyperhydration and decompensated cardiac insufficiency, acute stroke

          -  Known hypersensitivity to egg-, soy-, and peanut proteins or any of the ingredients
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jianchun Yu, Prof.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Peking Union Medical College Hospital,Department of Gastrointestinal Surgery</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Peking Union Medical College Hospital,Department of Gastrointestinal Surgery</name>
      <address>
        <city>Beijing</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>January 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 23, 2010</study_first_submitted>
  <study_first_submitted_qc>November 23, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 24, 2010</study_first_posted>
  <last_update_submitted>January 9, 2012</last_update_submitted>
  <last_update_submitted_qc>January 9, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 10, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

